Stephen E. Jones

Array ( [id] => 19345161 [patent_doc_number] => 20240254124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => AZAINDOLE ROCK INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/610051 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18610051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19940218 [patent_doc_number] => 12312340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins [patent_app_type] => utility [patent_app_number] => 18/590713 [patent_app_country] => US [patent_app_date] => 2024-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 179 [patent_no_of_words] => 122370 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19673887 [patent_doc_number] => 12185722 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-07 [patent_title] => Emulsifiable concentrate (EC) formulation of nitenpyram [patent_app_type] => utility [patent_app_number] => 18/436569 [patent_app_country] => US [patent_app_date] => 2024-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 9082 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19201378 [patent_doc_number] => 20240173277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => ANTI-MYCOBACTERIAL DRUGS [patent_app_type] => utility [patent_app_number] => 18/388696 [patent_app_country] => US [patent_app_date] => 2023-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18388696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19090952 [patent_doc_number] => 11952382 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-04-09 [patent_title] => 2-benzo-[3,4-b]quinolino-[b,g]indeno[1,2:3,4]fluoreno-[1,2-d]oxonine-24-flouro-5,11,16,21-tetraone as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/387550 [patent_app_country] => US [patent_app_date] => 2023-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3898 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18387550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18995844 [patent_doc_number] => 11912671 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-02-27 [patent_title] => Ethyl 3-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4- triazol-3-ylthio)propanoate as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/382834 [patent_app_country] => US [patent_app_date] => 2023-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4013 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19060097 [patent_doc_number] => 11939305 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-03-26 [patent_title] => Ethyl 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetate as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/489805 [patent_app_country] => US [patent_app_date] => 2023-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4009 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18489805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19018854 [patent_doc_number] => 20240075025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => Therapy for Mitochondrial Fatty Acid Beta-Oxidation and Transport Disorders [patent_app_type] => utility [patent_app_number] => 18/376188 [patent_app_country] => US [patent_app_date] => 2023-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19067113 [patent_doc_number] => 20240101539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS [patent_app_type] => utility [patent_app_number] => 18/220737 [patent_app_country] => US [patent_app_date] => 2023-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 126764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19372872 [patent_doc_number] => 12064411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-08-20 [patent_title] => Methods of administering solriamfetol to lactating women [patent_app_type] => utility [patent_app_number] => 18/323229 [patent_app_country] => US [patent_app_date] => 2023-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11664 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18769302 [patent_doc_number] => 20230364060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS [patent_app_type] => utility [patent_app_number] => 18/321266 [patent_app_country] => US [patent_app_date] => 2023-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19246722 [patent_doc_number] => 20240197706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => METHODS OF IMPROVING THE PHARMACOKINETICS OF MIGALASTAT [patent_app_type] => utility [patent_app_number] => 18/315928 [patent_app_country] => US [patent_app_date] => 2023-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18595906 [patent_doc_number] => 20230270696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => MEDICINAL USE OF FINGOLIMOD IN PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES CAUSED BY SPHINGOLIPID DISORDERS [patent_app_type] => utility [patent_app_number] => 18/314781 [patent_app_country] => US [patent_app_date] => 2023-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18535923 [patent_doc_number] => 20230241009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => Pharmaceutical Composition Of S-Ketamine Hydrochloride [patent_app_type] => utility [patent_app_number] => 18/296752 [patent_app_country] => US [patent_app_date] => 2023-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18970294 [patent_doc_number] => 20240050386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => MITOFUSIN ACTIVATORS HAVING AN ENDOCYCLIC-BONDED CARBONYL GROUP AND METHODS FOR USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/547996 [patent_app_country] => US [patent_app_date] => 2023-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12752 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18938241 [patent_doc_number] => 20240033380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 18/193570 [patent_app_country] => US [patent_app_date] => 2023-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18193570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18784676 [patent_doc_number] => 20230372279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN [patent_app_type] => utility [patent_app_number] => 18/185935 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18737864 [patent_doc_number] => 20230346764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors [patent_app_type] => utility [patent_app_number] => 18/119522 [patent_app_country] => US [patent_app_date] => 2023-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20451802 [patent_doc_number] => 12514845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Ionic-liquid-based formulations for the prevention or treatment of neurological diseases [patent_app_type] => utility [patent_app_number] => 18/725257 [patent_app_country] => US [patent_app_date] => 2023-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 11803 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18725257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18404508 [patent_doc_number] => 20230165859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => N-SUBSTITUTED INDOLE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/058873 [patent_app_country] => US [patent_app_date] => 2022-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058873 [rel_patent_id] =>[rel_patent_doc_number] =>)